Previous 10 | Next 10 |
home / stock / myco:cc / myco:cc news
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced that it will be attending three investor conferences in March. The upcoming events include the 34th Annual Ro...
DENVER, March 03, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced the ...
The National Endowment for the Arts is sponsoring an arts therapy initiative known as Creative Forces in partnership with the Department of Veterans Affairs and Department of Defense. Art therapies are increasingly being used to treat various brain conditions, including Alzheimer’s,...
A new study has linked the use of psilocybin with a reduction in the likelihood of an individual engaging in criminal behavior. Psilocybin is the active compound found in hallucinogenic mushrooms. Harvard University clinical psychology PhD candidate Grant Jones, the author of the study, ...
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced a positive meeting with the Food and Drug Administration (“FDA”) regarding the company’s ...
DENVER, March 01, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced a positiv...
Mydecine announced the inclusion of a patent-pending novel molecule in its family of psilocin analogs, MYCO-005 This molecule features potentially heart-safe microdose-enabling properties, addressing the delivery and stability concerns associated with the first-generation compounds My...
Vancouver Island University (“VIU”) plans to launch its psychedelic-assisted therapy course in September of this year. This will make it the first accredited university in Canada to offer this course for healthcare professionals, under its Faculty of Health and Human Services...
Mydecine (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has released a video discussing the company’s fully integrated approach to drug development. “At Mydecine,...
Studies suggest that psychedelics such as psilocybin and MDMA offer health benefits when used to treat patients with depression and PTSD These results have encouraged scientists, psychotherapists, and entrepreneurs, who say that FDA approvals may be on the horizon Mydecine is playing ...
News, Short Squeeze, Breakout and More Instantly...
MYDECINE INNOVATIONS GROUP INC. Company Name:
MYCO:CC Stock Symbol:
AQNC Market:
MYDECINE INNOVATIONS GROUP INC. Website:
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 1.6% to $49.86 on volume of 16,918,783 shares Cenovus Energy Inc. (CVE) rose 1.2% to $27.09 on volume of 11,032,869 shares Toronto-Dominion Bank (The) (TD) rose 1.0% to $76.74 on volume of 10,871,605...
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.3% to $76.13 on volume of 16,847,005 shares Canadian Natural Resources Limited (CNQ) fell 1.5% to $48.33 on volume of 7,922,140 shares TC Energy Corporation (TRP) rose 0.1% to $51.11 on volume of 7,293,869...
(TheNewswire) Vancouver, British Columbia, July 5, 2024— TheNewswire – Mydecine Innovations Group Inc. (the “ Company ”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) is pleased to confirm that further to its news release dated June 13, 2024, ...